Evidence map›Paper›PMID 25352621›Full record

ArticlemBio2014

RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry.

Krishnamurthy Malathi, Mohammad Adnan Siddiqui, Shubham Dayal, Merna Naji, Heather J Ezelle, Chun Zeng, Aimin Zhou, Bret A Hassel

Open access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Zika virus employs the host antiviral RNase L protein to support replication factory assembly.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. The Unusual Role of Ribonuclease L in Innate Immunity.Wiley interdisciplinary reviews. RNA
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Krishnamurthy MalathiDepartment of Biological Sciences, University of Toledo, Toledo, Ohio, USA Malathi.Krishnamurthy@utoledo.edu.
Mohammad Adnan SiddiquiDepartment of Biological Sciences, University of Toledo, Toledo, Ohio, USA.
Shubham DayalDepartment of Biological Sciences, University of Toledo, Toledo, Ohio, USA.
Merna NajiDepartment of Biological Sciences, University of Toledo, Toledo, Ohio, USA.
Heather J Ezelle
Chun ZengDepartment of Chemistry, Cleveland State University, Cleveland, Ohio, USA.
Aimin Zhou
Bret A Hassel
University of Toledo · USCleveland State University · USUniversity of Maryland, Baltimore · USUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Funding

Role of the antiviral ribonuclease, RNase-L, in the host antibacterial responseR01AI077556 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HASSEL, BRET A · 2009 to 2012
$1.6M
Role of small RNAs in innate immunity and inflammationR15AI089518 · NIAID · UNIVERSITY OF TOLEDO · PI KRISHNAMURTHY, MALATHI · 2010 to 2010
$430k
The involvement of RNase L in the pathogenesis of inflammatory bowel diseaseR15DK084460 · NIDDK · CLEVELAND STATE UNIVERSITY · PI ZHOU, AIMIN · 2011 to 2011
$336k
NIAID NIH HHS AI077556NIAID NIH HHS AI089518NIAID NIH HHS R01 AI077556NIAID NIH HHS R15 AI089518NIDDK NIH HHS DK084460-01A2NIDDK NIH HHS R15 DK084460
6 · The paper itself

Abstract

unlabelledThe actin cytoskeleton and its network of associated proteins constitute a physical barrier that viruses must circumvent to gain entry into cells for productive infection. The mechanisms by which the physical signals of infection are sensed by the host to activate an innate immune response are not well understood. The antiviral endoribonuclease RNase L is ubiquitously expressed in a latent form and activated upon binding 2-5A, a unique oligoadenylate produced during viral infections. We provide evidence that RNase L in its inactive form interacts with the actin-binding protein Filamin A to modulate the actin cytoskeleton and inhibit virus entry. Cells lacking either RNase L or Filamin A displayed increased virus entry which was exacerbated in cells lacking both proteins. RNase L deletion mutants that reduced Filamin A interaction displayed a compromised ability to restrict virus entry, supporting the idea of an important role for the RNase L-Filamin A complex in barrier function. Remarkably, both the wild type and a catalytically inactive RNase L mutant were competent to reduce virus entry when transfected into RNase L-deficient cells, indicating that this novel function of RNase L is independent of its enzymatic activity. Virus infection and RNase L activation disrupt its association with Filamin A and release RNase L to mediate its canonical nuclease-dependent antiviral activities. The dual functions of RNase L as a constitutive component of the actin cytoskeleton and as an induced mediator of antiviral signaling and effector functions provide insights into its mechanisms of antiviral activity and opportunities for the development of novel antiviral agents. IMPORTANCE: Cells constantly face and sample pathogens on their outer surface. The actin cytoskeleton and interacting proteins associate with the cell membrane and constitute a barrier to infection. Disruption of the actin cytoskeleton allows viruses to enter the cell and induces innate immune responses to clear infections. The molecular mechanisms that link virus-induced physical perturbations to host defense pathways remain unclear. Our studies identified a novel interaction between the antiviral endoribonuclease RNase L and the actin-binding protein Filamin A that enhances host defense by preventing viral entry into naive cells. This role for RNase L is independent of its enzymatic function. Virus infection alters actin dynamics, disrupts the RNase L-Filamin A complex, and releases RNase L to mediate antiviral signaling and effector functions via its established nucleolytic activities. These dual roles for RNase L provide an efficient strategy to protect cells from infection and rapidly respond upon pathogen exposure.

Indexed as

Host-Pathogen InteractionsVirus InternalizationActinsCell LineEndoribonucleasesFilaminsHumansSendai virus2-5A-dependent ribonucleaseActinsEndoribonucleasesFilamins

Identifiers

PMID25352621
PMCPMC4217177
OpenAlexW2108141883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.